Is body mass index the prognostic factor in breast cancer?: A meta-analysis

Journal of Korean Medical Science

Volumn 16, Issue 5, 2001, Pages 610-614

  Ryu, So Yeon ^a   Kim, Chun Bae ^b   Nam, Chung Mo ^c   Park, Jong Ku ^b   Kim, Ki Soon ^a   Park, Jong ^a   Yoo, Soo Young ^b   Cho, Kyung Sook ^b  

^a Chosun University   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Body mass index; Breast neoplasms; Meta analysis; Prognosis

Indexed keywords

ARTICLE; BODY MASS; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; META ANALYSIS; MORTALITY; PROGNOSIS;

BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; PROGNOSIS;

EID: 0035489621     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2001.16.5.610     Document Type: Article

References (48)

1. Parkin DM, Stjemsward J, Muir C. Estimates of worldwide frequency of twelve major cancers. B World Health Organ 1984; 62: 163-82.
2. Canadian Cancer Society. Canadian Cancer Statistics 1987. Toronto, Canada, 1987.
3. Korean Ministry of Health & Welfare. Analysis of Korean cancer registration data (1993), 1995.
4. Yoo KY, Noh DY, Choi KJ. Epidemiology of breast cancer in Korea. Korean J Epidemiol 1995; 17: 30-47.
5. Yoo KY, Park SK, Sung JH, Kang DH, Kim YC, Kang HS, Suh JS, Kim JS, Yoon IJ, Han SH, Noh DY, Choi KJ. High risk group for female breast cancer in Korea. J Korean Cancer Assoc 1998; 30: 435-49.
6. National Statistical Office Republic of Korea. 1998 annual report on the cause of death statistics (based on vital registration), 1999.
7. Gloecker-Reis L, Pollack ES, Young JL. Cancer patient survival. J Natl Cancer Inst 1983; 70: 693-707.
8. Galanis DJ, Kolonel LN, Lee J, Le Marchand L. Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii, United States. Cancer Causes Control 1998; 9: 217-24.
9. Muller CB, Ames F, Anderson GD. Breast cancer in 3558 women: age as a significant determinant in the rate of dying and causes of death Surgery 1978; 83: 123-32.
10. Palmer MK, Lythgoe JP, Smith A. Prognostic factors in breast cancer. Br J Surgery 1982; 69: 697-8.
11. Rutqvist LE, Wallgren A. Influence of age on outcome in breast carcinoma. Acta Radiol Oncol 1983; 22: 289-94.
12. Velentgas P, Daling JR. Risk factors for breast cancer in younger women. J Natl Cancer Inst Monogr 1994; 16: 15-24.
13. Cutler SJ, Asire AJ, Taylor SG III. An evaluation of ovarian status as prognostic factor in disseminated cancer of the breast. Cancer 1970; 26: 938-43.
14. Langlands AO, Kerr GR. Prognosis in breast cancer: the effect of age and menstrual status. Clin Oncol 1979; 5: 123-33.
15. Ursin G, Longnecker MP, Haile RW, Greenland S. A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 1995; 6: 137-41.
16. Wilkinson GS, Edgerton F, Wallace HJ, Resse P, Patterson J, Priore R. Delay, stage of disease and survival from breast cancer. J Chronic Dis 1979; 32: 365-73.
17. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551-7.
18. Clark GM, McGuire WL, Hubay CA, Person OH, Marshall JS. Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 1983; 309: 1343-7.
19. Manni A. Hormone receptors and breast cancer. N Engl J Med 1983; 309: 1383-5.
20. Abe R, Kumagi N, Kimura M, Hirosaki Am Nakamura T. Biological characteristics of breast cancer in obesity. Tohoku J Exp Med 1976; 120: 351-9.
21. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res Treat 1990; 16: 205-14.
22. Mohle-Boetani J, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS Jr. Body size, reproductive factors and breast cancer survival Prev Med 1988; 17: 634-42.
23. Greenberg ER, Vessy MP, Mcpherson K, Doll R, Yeates D. Body-size and survival in premenopausal breast cancer. Br J Cancer 1985; 51: 691-7.
24. Kyogoku S, Hirohata T, Takeshita S, Nomura Y, Shigematsu T, Horie A. Survival of breast-cancer patients and body size indicators. Int J Cancer 1990; 46: 824-31.
25. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987; 9: 1-30.
26. Prentice RL, Thomas DB. On the epidemiology of oral contraceptives and disease. Adv Cancer Res 1987; 49: 285-401.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
28. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315: 629-34.
29. den Tonkelaar I, de Waard F, Seidell JC, Fracheboud J. Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project. Breast Cancer Res Treat 1995; 34: 129-37.
30. Tomberg S, Carstensen J. Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur J Cancer 1993; 29A: 2025-30.
31. Eley W, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, Hunter CP, Herman AA, Kurman R, Blacklow R, Shapiro S, Edwards BK. Racial differences in survival from breast cancer. Results of the national cancer institute black/white cancer survival study. JAMA 1994; 272: 947-54.
32. Holmberg L, Lund E, Bergstrom R, Adami HO, Meirik O. Oral contraceptives and prognosis in breast cancer: effects of duration, latency, residency, age at first use and relation to parity and body mass index in young women with breast cancer. Eur J Cancer 1994; 30A: 351-4.
33. Jain M, Miller AB. Pre-morbid body size and the prognosis of women with breast cancer. Int J Cancer 1994; 59: 363-8.
34. Zhang S, Folsom AR, Sellers TA, Kushi LH, Potter JD. Better breast cancer survival for postmenopausal women who are less ovenveight and eat less fat. The Iowa women's health study. Cancer 1995; 76: 275-83.
35. Maehle BO, Tretli S. Pre-morbid body mass index in breast cancer: reversed effect on survival in hormone receptor negative patients. Breast Cancer Res Treat 1996; 41: 123-30.
36. Saxe GA, Rock CL, Wicha MS, Schottenfeld D. Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 1999; 53: 241-53.
37. Petitti DB. Meta-analysis, decision analysis and cost-effectiveness analysis-methods for quantitative synthesis in medicine. New York, Oxford University Press, 1994.
38. Egger M, Smith GD. Misleading meta-analysis. Lessons from "an effective, safe, simple" intervention that wasn't. Br Med J 1995; 310: 752-4.
39. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research Lancet 1991; 337: 867-72.
40. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomized controlled trials published in English and German. Lancet 1997; 350: 326-9.
41. Petitti DB. Of babies and bathwater. Am J Epidemiol 1994; 140: 779-82.
42. Light RJ, Pillemer DB. Summing up. The science of reviewing research. Cambridge, MA: Harvard University Press, 1984.
43. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta Analysis. J Clin Epidemiol 1995; 48(1): 167-71.
44. Shapiro S. Meta-analysis/Shmeta-analysis. Am J Epidemiol 1994; 140: 771-8.
45. Davey Smith G, Egger M, Phillips AN. Meta-analysis and data synthesis in medical research. In: Oxford Textbook of Public Health (Vol 2). New York, Oxford University Press, 1997: 631-50
46. Greenland S. Can meta-analysis be salvaged? Am J Epidemiol 1994; 140: 783-7.
47. Bailar JC III. The practice of meta-analysis. J Clin Epidemiol 1995; 48: 149-57.
48. Mosteller F, Colditz GA. Understanding research synthesis (meta-analysis). Annu Rev Public Health 1996; 17: 1-23.